KYTHERA BIOPHARMACEUTICALS I's ticker is KYTH and the CUSIP is 501570105. A total of 145 filers reported holding KYTHERA BIOPHARMACEUTICALS I in Q3 2015. The put-call ratio across all filers is 1.04 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2015 | $7,681,000 | +36.6% | 101,989 | -9.0% | 0.44% | +36.6% |
Q1 2015 | $5,621,000 | +64.7% | 112,080 | +13.9% | 0.32% | +57.0% |
Q4 2014 | $3,412,000 | +56.7% | 98,378 | +48.0% | 0.21% | +36.2% |
Q3 2014 | $2,178,000 | +99.8% | 66,486 | +134.0% | 0.15% | +108.2% |
Q2 2014 | $1,090,000 | +17.3% | 28,416 | +21.6% | 0.07% | +7.4% |
Q1 2014 | $929,000 | – | 23,365 | – | 0.07% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
AlpInvest Partners B.V. | 33,271 | $1,277,000 | 4.55% |
Palo Alto Investors LP | 949,959 | $36,450,000 | 2.71% |
Redmile Group, LLC | 560,356 | $21,501,000 | 2.61% |
SENZAR ASSET MANAGEMENT, LLC | 124,900 | $4,792,000 | 1.83% |
Aureus Asset Management, LLC | 152,662 | $5,858,000 | 1.46% |
PFM Health Sciences, LP | 952,715 | $36,556,000 | 0.73% |
REGENTATLANTIC CAPITAL LLC | 176,454 | $6,771,000 | 0.63% |
Polar Capital LLP | 519,398 | $19,927,000 | 0.42% |
FNY Managed Accounts LLC | 2,500 | $95,925,000 | 0.35% |
Partner Investment Management, L.P. | 36,173 | $1,388,000 | 0.28% |